King Abdulaziz University Hospital

Jeddah 22254

2 studies enrolling now · 9 studies all time

What they study most

Atrial Fibrillation, Cardiovascular Diseases, Critical Illness, Deep Venous Thrombosis, Diabetes Mellitus, Type 2, Heart Failure, Heart Failure With Left Bundle Branch Block, Hemophilia A, Hemophilia B, Hypertension, Obesity, Stroke

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
• Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories — Completed
• A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) — Completed
• Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B — Completed
• AdaptResponse Clinical Trial — Completed
• Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission. — Stopped early
• GLORIA-AF Registry Program - Second and Third Phases — Completed
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT) — Completed